Navamedic
Develops, produces, and commercializes medicines and related health products.
NAVA | OL
Overview
Corporate Details
- ISIN(s):
- NO0010205966
- LEI:
- 529900LKVQOR2SRUJU71
- Country:
- Norway
- Address:
- Henrik Ibsens gate 100, 0255 OSLO
- Website:
- https://navamedic.com/
- Sector:
- Wholesale and retail trade
- Industry:
- Other specialized wholesale
Description
Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-22 07:30 |
Navamedic ASA: Commencement of the subscription period for the rights issue
|
English | HTML • 13.5 KB | ||
| 2025-09-19 11:05 |
Navamedic ASA: Approval and publication of prospectus
|
English | HTML • 10.7 KB | ||
| 2025-08-28 15:19 |
Flaggemelding
|
Norwegian | HTML • 465 bytes | ||
| 2025-08-14 07:00 |
Navamedic ASA: Rapport for 2. kvartal og første halvår 2025 - Attachment: Navam…
|
English | PDF • 2.8 MB | ||
| 2025-08-14 07:00 |
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025 - At…
|
English | PDF • 2.8 MB | ||
| 2025-08-14 07:00 |
Navamedic ASA: Rapport for 2. kvartal og første halvår 2025 - Attachment: Navam…
|
English | PDF • 836.1 KB | ||
| 2025-08-14 07:00 |
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025 - At…
|
English | PDF • 836.1 KB | ||
| 2025-08-14 07:00 |
Navamedic ASA: Rapport for 2. kvartal og første halvår 2025
|
Norwegian | HTML • 5.9 KB | ||
| 2025-08-14 07:00 |
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025
|
English | HTML • 5.9 KB | ||
| 2025-08-13 09:51 |
Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all No…
|
English | HTML • 2.9 KB | ||
| 2025-08-11 13:03 |
Navamedic ASA: Invitation to 2025 2nd quarter presentation
|
English | HTML • 2.0 KB | ||
| 2025-07-15 12:32 |
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
|
English | HTML • 5.7 KB | ||
| 2025-07-15 08:25 |
Navamedic ASA: Ex. subscription rights today
|
English | HTML • 523 bytes | ||
| 2025-07-14 15:27 |
Navamedic ASA - Minutes of Extraordinary General Meeting - Attachment: Navamedi…
|
Norwegian | PDF • 354.3 KB | ||
| 2025-07-14 15:27 |
Navamedic ASA - Minutes of Extraordinary General Meeting
|
English | HTML • 1.0 KB |
Automate Your Workflow. Get a real-time feed of all Navamedic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Navamedic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Navamedic via our API.
Peer Companies
